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Abstract: Baccharis trimera is a plant popularly used as a tea and to treat gastrointestinal 
diseases and inflammatory processes as well. The total phenolic content was determined 
and the antioxidant and anti-inflammatory activities of six extracts (dichloromethane,   
ethyl acetate, butanol, aqueous, saponin and phenolic) from B. trimera were evaluated. 
Using carrageenan-induced pleurisy as a model of acute inflammation, the phenolic extract 
at 15 mg/kg decreased significantly the analyzed parameters when compared to the 
carrageenan group (p < 0.05), thus showing potential anti-inflammatory activity. The total 
phenolic content and antioxidant activity were evaluated by the Folin-Ciocalteau and 
DPPH methods, respectively. Phenolic and ethyl acetate extracts presented higher 
antioxidant activity (p < 0.05) than ascorbic acid. The phenolic extract also showed the 
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highest antioxidant potential in relation to the other extracts, thus suggesting that the 
antioxidant and anti-inflammatory activities were due to the presence of phenolic compounds. 
Keywords: anti-inflammatory; antioxidant; Baccharis trimera; phenolic compounds; 
pleurisy; saponin; TAR 
 
1. Introduction 
Baccharis trimera, a member of the Asteraceae, is a shrub native to South Brazil, Paraguay, 
Uruguay and Argentina. Medicinal teas prepared from its aerial parts are used in folk medicine to treat 
not only gastrointestinal and liver diseases, but also inflammatory processes [1] and it is the official 
species of the Brazilian Pharmacopoeia [2]. Literature mainly cites the presence of volatile oil, 
flavones, flavonol, saponins and diterpenes [3–7]. The flavonoids reported so far to B. trimera were 
apigenin, 7,4'-di-O-methyl-apigenin, cirsimaritin, eupatorin, genkwanin, hispidulin, isoquercetin, luteolin, 
nepetin, quercetin, 3-O-methylquercetin, 5,6-dihydroxy-7,3',4'-trimethoxyflavone and rutin [8–10].   
In relation to its pharmacological activity, several studies demonstrated the anti-inflammatory activity 
of its ethanol and aqueous extracts, as well as analgesic, antioxidant, antihepatotoxic and antimutagenic 
activities [8,9,11,12]. Recently, our group demonstrated that the crude aqueous extract of B. trimera 
presented anti-inflammatory activity at the doses of 400 and 800 mg/kg [13]. 
Considering the previous biological activity studies of B. trimera, chemical and pharmacological 
studies using bioassay-guided fractionation of B. trimera were initiated by our group in order to 
identify its anti-inflammatory and antioxidant compounds. The investigation of its lead compounds 
should contribute to new drug discovery. 
2. Results and Discussion 
In this study, the phenolic content, the anti-inflammatory and antioxidant activities of B. trimera 
extracts were studied using a bioassay-guided fractionation. Extracts with major compounds were 
obtained as enriched phenolic and saponin extracts. 
TLC analyses showed a predominance of phenolic and terpenoid compounds in the ethyl acetate 
and butanol fractions. This was verified by TLC using anisaldehyde-H2SO4/100 °C through visualization 
of violet spots in both fractions, a color characteristic of terpenoid compounds. Also, using the Natural 
Reagent A/UV356, it was possible to observe yellow spots corresponding to phenolic compounds 
present in these same B. trimera fractions. Both fractions were pooled together and submitted to 
molecular permeation chromatography to obtain one extract presenting only yellow spots, named the 
phenolic (PHE) extract, and another one presenting only violet spots, and named saponin (SAP) extract. 
The phenolic content determined by the Folin-Ciocalteau method correlated with the antioxidant 
activity determined using the DPPH test. The total phenolic content of samples ranged from 107 to 
1,482 mg of gallic acid/g of dry sample (Table 1). The phenolic (1,482.02 ± 50.41 mg of gallic acid/g 
of dry sample) and the ethyl acetate extracts (1,387.95 ± 42.45 mg of gallic acid/g of dry sample) 
presented the highest amounts of phenolic compounds. Molecules 2012, 17 1115 
 
 
Table 1. Total phenolic content in B. trimera extracts. 
Samples Phenolic  content 
a (GAE/g)
Crude ethanol   261.59 ± 8.75 
Dichloromethane   126.93 ± 5.52 
Ethyl acetate   1387.95 ± 42.45 
Butanol   107.71 ± 2.07 
Aqueous   455.29 ± 24.9 
Saponin   223.02 ± 28.86 
Phenolic   1482.02 ± 50.41 
a Results are expressed as means ± S.D (n = 3) in mg of gallic acid equivalent/g of dry weight. 
Moreover the phenolic extract presented the best antioxidant activity (IC50 1.57 μg/mL) in 
comparison to ascorbic acid (AA) (IC50 3.38 μg/mL) and samples (Table 2). As to other Baccharis 
species, the antioxidant activity IC50 values of crude extract, ethyl acetate and aqueous fraction from  
B. pentlandii DC. were 56.7 ± 1.2, 15.0 ± 0.3 and 50.3 ± 1.2 µg/mL, respectively, and from   
B. platipoda were 49.5 ± 0.8, 20.5 ± 1.3 and 73.3 ± 8.6 µg/mL, respectively [14]. Considering isolated 
compounds, quercetin (IC50 = 3.73 μg/mL) demonstrated very good antioxidant activities [15]. 
Table 2. IC50 and corresponding AEAC obtained using DPPH assay in B. trimera extracts. 
Samples IC50 (µg/mL)  AEAC (g) 
Ascorbic acid (AA)  3.38  1 
Crude ethanol   15.49  4.58 
Dichloromethane   29.95  8.85 
Ethyl acetate   6.25  1.85 
Butanol   8.24  2.44 
Aqueous   50.87  15.03 
Saponin   10.25  3.03 
Phenolic   1.57  0.46 
Quercetin 2.41  0.71 
Luteolin 2.84  0.84 
AEAC, ascorbic acid equivalent antioxidant capacity. 
Regarding the TAR determination, ascorbic acid (AA) was used as a reference due to its potent 
antioxidant activity. The phenolic extract presented a TAR value comparable to AA (Figure 1) 
moreover this sample showed a significant increase (p < 0.001) in total antioxidant reactivity in 
comparison to the other samples tested and the control.  
Inflammation is a protective process that is essential for the preservation of the integrity of the 
organism in the events of chemical, physical and infectious damages. In our experiments, intrapleural 
injection of carrageenan induced an acute inflammatory reaction, characterized by marked accumulation 
of a volume of pleural exudates, plasma exudation and intense migration of PMNs in the pleural cavities. 
In previous phytochemical studies of some Baccharis species, the potential antioxidant activity of 
crude extract from B. trimera [12] was identified by our group. Also, our group determined that Molecules 2012, 17 1116 
 
 
aqueous extract from B. trimera at 400 and 800 mg/kg presented anti-inflammatory activity using the 
carragenan pleurisy model i.p. [13]. 
Figure 1. Total antioxidant reactivity (TAR, nmL/Trolox/mg protein) of extracts   
(DCM: 0.5 mg/mL; BU: 1 mg/mL; AQ: 1 mg/mL; SAP: 1 mg/mL and PHE: 1 mg/mL)  
and control. Results are expressed as means ± S.D. Significant differences determined by 
ANOVA complemented with Tukey’s test. 
### p < 0.001 control vs. fractions and acid 
ascorbic, *** p < 0.001 acid ascorbic vs. control and extracts, 
aaa p < 0.001 phenolic extract 
vs. other extracts (DCM, BU, AQ and SAP). 
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Herein the B. trimera extracts assayed (DCM, EA, BU and AQ at 25, 50 and 75 mg/kg, i.p.) (Table 3) 
on pleurisy inflammation induced by carrageenan were effective in inhibiting the volume of exudation, 
leukocyte migration, leukocytes differential cell count and protein concentration. 
Moreover, when testing the enriched extracts containing phenolic compounds at doses of 5 and  
15 mg/kg or saponins at doses of 15, and 30 mg/kg, it could be demonstrated that the phenolic 
enriched extract presented the best anti-inflammatory activity at 15 mg/kg. So, animals treated with 
saponin extract (Figure 2) at doses of 15 and 30 mg/kg, i.p., had their volume of exudate significantly 
decreased at 30 mg/kg (22.34 ± 0.22 % inhibition, p < 0.01) when compared to carrageenan. In both 
doses, SAP considerably reduced the leukocyte migration (22.04 ± 6.99 and 61.96 ± 3.44% inhibition, 
p < 0.05), and the neutrophil decreased as well (56.34 ± 13.3 and 59.72 ± 8.51% inhibition, p < 0.001) 
when compared to carrageenan. Protein concentration significantly decreased at doses of 15 and   
30 mg/kg, i.p. (47.04 ± 0.41 and 68.78 ± 0.35 % inhibition, p < 0.05) when compared to carrageenan. 
 Molecules 2012, 17  1117 
 
Table 3. Effects of B. trimera extracts on pleurisy inflammation parameters induced by carrageenan and on nitric oxide levels. 
Groups/dose  volume of exudation (mL) Total Leukocytes (×10
6/cavity) PMNs (×10
6/cavity) Protein (g/dL)  NO (nmol/cavity) 
Saline  2.06 ± 0.05  10.57 ± 2.55  3.12 ± 0.38  0.16 ± 0.12  4.44 ± 3.37 
Carrageenan  2.96 ± 0.15 ***  37.47 ± 21.88 **  43.70 ± 18.71 ***  2.25 ± 0.46 ***  70.53 ± 18.06 
Dexamethasone 2.12 ± 0.09 
aaa 19.05 ± 3.57  2.79 ± 0.46 
aaa 0.50 ± 0.04 
aaa 39.97 ± 11.73 
DCM 25 mg/kg 2.46 ± 0.13 **
aaa&& 8.79 ± 2.53 
aa 5.90 ± 0.42 
aa 0.54 ± 0.20 
aaa 12.67 ± 4.48 
aaa& 
DCM 50 mg/kg 2.42 ± 0.19 **
aaa& 7.52 ± 0.98 
aa 4.30 ± 0.49 
aaa 0.62 ± 0.34 
aaa 17.71 ± 4.17 
aaa 
DCM 75 mg/kg 2.34 ± 0.18 
aaa 8.03 ± 1.99 
aa 4.00 ± 0.69 
aaa 0.69 ± 0.12 
aaa 19.93 ± 4.49 
aaa 
EA 25 mg/kg  2.45 ± 0.23 **
aaa&& 17.71 ± 7.50 
aa 10.45 ± 5.16 
a 0.48 ± 0.26 
aaa 17.51 ± 6.94 
aaa 
EA 50 mg/kg  2.35 ± 0.12 *
aaa 11.97 ± 4.04 
aaa 2.66 ± 1.96 
aa 0.59 ± 0.43 
aaa 17.69 ± 15.89 
aaa 
EA 75 mg/kg  2.32 ± 0.08 
aaa 6.42 ± 1.34 
aaa& 2.43 ± 0.15 
aa 0.48 ±0.21 
aaa 20.62 ± 26.93 
aaa 
BU 25 mg/kg  2.51 ± 0.23 ***
aaa&&&# 20.20 ± 14.54 *
a 15.25 ± 12.79 
a 1.31 ± 0.55 ***
a& 15.91 ± 5.54 
aaa&& 
BU 50 mg/kg  2.33 ± 0.13 
aaa 11.45 ± 3.00 
aa 2.86 ± 0.58 
aaa 1.01 ± 0.37 **
aa 12.26 ± 4.44 
aaa&& 
BU 75 mg/kg  2.25 ± 0.14 
aaa 9.93 ± 2.40 
aaa 2.80 ± 0.42 
aaa 0.92± 0.28 *
aaa 10.67 ± 3.44 
aaa&& 
AQ 25 mg/kg  2.35 ± 0.34 
aaa 15.12 ± 11.99 
aa 38.15 ± 4.59 *  0.99 ±0.81 *
aaa 26.75 ± 17.00 
aaa 
AQ 50 mg/kg  2.16 ± 0.15 
aaa 7.28 ± 6.40 
aaa 2.00 ± 0.28 
aa 0.44 ± 0.22 
aaa 25.97 ± 17.00 
aaa 
AQ 75 mg/kg  2.16 ± 0.12 
aaa 8.96 ± 5.46 
aaa 3.70 ± 1.10 
aa 0.34 ± 0.26 
aaa 28.77 ± 24.49 
aaa 
Results are expressed as means ± S.D (n = 7). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. saline; 
a p < 0.05, 
aa p < 0.01, 
aaa p < 0.001 vs. carrageenan and  
& p < 0.05, 
&& p <0.01, 
&&& p < 0.001 vs. dexamethasone (ANOVA complemented with Bonferroni’s test). 
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Figure 2. Effects of SAP B. trimera extract on inflammation induced by carrageenan. 
Significant differences were determined by ANOVA complemented with Bonferroni’s test. 
Results are expressed as means ± S.D (n = 7). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. 
saline; 
a p < 0.05, 
aa p < 0.01, 
aaa p < 0.001 vs. carrageenan and 
& p < 0.05, 
&& p < 0.01,  
&&& p < 0.001 vs. dexamethasone. 
 
Animals treated with phenolic extract (at doses of 5 and 15 mg/kg, i.p.) (Figure 3) had their volume 
of exudates decreased only at dose of 15 mg/kg, i.p. (21.31 ± 0.16% inhibition, p < 0.001) when 
compared to carrageenan and they also had their leukocyte migration significantly decreased at doses 
of 5 and 15 mg/kg, i.p. (46.79 ± 19.65 and 63.35 ± 13.53% inhibition, p < 0.05). The neutrophil influx 
also significantly decreased (30.00 ± 18.01 and 54.42 ± 11.78% inhibition, p < 0.05) and the reduction 
of protein concentration occurred from 49.38 ± 0.40 to 60.01 ± 0.45% of inhibition (p < 0.05), at the 
doses of 5 and 15 mg/kg, i.p. when compared to carrageenan. 
Figure 3. Effects of PHE B. trimera extract on inflammation induced by carrageenan. 
Significant differences were determined by ANOVA complemented with Bonferroni’s test. 
Results are expressed as means ± S.D (n = 7). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. 
saline; 
a p < 0.05, 
aa p < 0.01, 
aaa p < 0.001 vs. carrageenan and 
& p < 0.05, 
&& p < 0.01,  
&&& p < 0.001 vs. dexamethasone. 
 
Nitric oxide (NO) is another important pro-inflammatory mediator involved in exudation and 
leukocyte migration in the inflammatory process. Evidence for the role of NO as a vasodilator and 
hyperpolarizing agent in the endothelial cells has been discussed [16]. Once again, B. trimera extracts 
demonstrated significant inhibition of NO levels. The extracts DCM, EA, BU and AQ at doses of 25, Molecules 2012, 17 1119 
 
 
50 and 75 mg/kg, i.p., presented percentages of inhibition varying from 59.21 to 77.44 (Table 3). 
Saponin extract only decreased the NO production at 30 mg/kg while phenolic extract at doses of 5 and 
15 mg/kg, i.p. caused a significant decrease of NO production when compared to carrageenan (Figure 4).  
Figure 4. Effects of B. trimera extracts (PHE and SAP) on nitric oxide levels. Significant 
differences were determined by ANOVA complemented with Bonferroni’s test. Results are 
expressed as means ± S.D (n = 7). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. saline;  
a  p < 0.05, 
aa  p < 0.01, 
aaa  p < 0.001 vs. carrageenan and 
&  p < 0.05, 
&&  p < 0.01,   
&&& p < 0.001 vs. dexamethasone. 
 
3. Experimental  
3.1. Plant Material 
B. trimera (Less.) DC plants were collected in Rio Grande do Sul, Brazil and identified by Prof. Dr. 
Nelson Matzenbacher from Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Brazil. 
A voucher specimen is deposited at the Herbarium (ICN 152107) of the Universidade Federal do Rio 
Grande do Sul. Aerial parts were air-dried and powdered. 
3.2. Chemical 
All chemicals were purchased from Sigma (Milwaukee, WI, USA), Fluka Chemie (Buchs, 
Switzerland) and Merck (Darmstadt, Germany) and they were of analytical grade. 
3.3. Extraction  
Aerial parts of B. trimera (1 kg) were extracted by maceration with ethanol 96% (plant:solvent, 
1:10, w/v, 2 × 15 days). The crude ethanol extract (CE, 130 g) was obtained after filtration and 
evaporation under vacuum. Aerial parts of B. trimera (50 g) were also exhaustively and successively 
extracted using a Soxhlet apparatus and the appropriate solvent, which provided in the corresponding 
dichloromethane (DCM, 10%), ethyl acetate (EA, 4%) and butanol (BU, 3%) extracts. The plant 
residue was submitted to decoction in order to obtain the residual aqueous extract (AQ, 14%).   
The ethyl acetate and butanol fractions were pooled together and submitted to molecular permeation 
chromatography on Sephadex LH-20 (Pharmacia) eluted with 99% ethanol to obtain the phenolic Molecules 2012, 17 1120 
 
 
(PHE, 19%) and the saponin (SAP, 63%) extracts. The organic solvents were evaporated under 
reduced pressure to dryness and the aqueous extract was lyophilized. All extracts were chemically 
characterized according our previous results [5]. 
3.4. Chromatographic Analysis 
Phytochemical profile of B. trimera was carried out by thin-layer chromatography (TLC) on silica 
gel plates GF254 using as mobile phase chloroform-ethanol-acetic acid (CHCl3:EtOH:HOAc, 60:40:6 v/v) 
and two color reagents: anisaldehyde-H2SO4 to detect terpenoid compounds and Natural Reagent A to 
visualize phenolic compounds [5,17]. 
3.5. Total Phenolic Determination 
The total phenolic content was determined using the Folin-Ciocalteau method [18].   
The standard curve was plotted using gallic acid (10–30 µg/mL) which regression equation was   
y = 0.0275x + 0.0104 (R
2 = 0.9993). The absorbance was measured at 750 nm and the results were 
expressed as mg of gallic acid equivalents per gram of dry weight sample (GEA/g). The experiment 
was conducted in triplicate. 
3.6. DPPH Assay 
The scavenging effect on DPPH was determined according to Brand-Williams et al. [19] using 
sample and reference substances concentrations from 25 to 200 µg/mL. The absorbance was measured 
at 515 nm and the experiment was conducted in triplicate. The DPPH solution in methanol was used as 
a negative control. As a positive control, ascorbic acid (AA), quercetin and luteolin were used.   
The antioxidant activity (AOA) was expressed as the concentration (g/mL) that inhibited DPPH 
radical formation by 50% (IC50) in comparison to the negative control. The lower the IC50 the higher 
the AOA. Results were also expressed as AEAC (ascorbic acid equivalent antioxidant capacity) in 
grams and calculated as follows: 
AEAC (g) = IC50(sample)/IC50(AA) × 1 g 
3.7. Total Antioxidant Reactivity (TAR) 
TAR, which represents the quality of the antioxidant sample, was determined by measuring the 
luminal chemiluminescence intensity induced by 2,2'-azo-bis-(2-amidinopropane) (ABAP) according 
to Lissi et al. [20]. The background chemiluminescence was measured by adding 4 mL of 2 mM ABAP 
(in 0.1 M glycine buffer, pH 8.6) into a glass scintillation vial. Fifteen microliters of luminol (4 mM) 
was added to each vial and the chemiluminescence was measured (basal value). Ten microliters from 
25 to 200 M Trolox (calibration curve) or sample was then added and the chemiluminescence was 
measured during 60 s. Both the Trolox and samples reduced the chemiluminescence. The rapid 
reduction in luminol intensity is considered as a measure of the TAR capacity calculated as nmol 
Trolox/mg protein. Protein concentrations were determined by Biuret method (Labtest Kit
®) using 
bovine serum albumin as standard. Molecules 2012, 17 1121 
 
 
3.8. Animals  
Female Wistar rats (3–4 months old, weighing 200–250 g) were employed in the experiments.  
The animals were kept on shelves with ventilated cages which provided 60 air cycles per hour, relative 
humidity ranging between 55–65%, a 12 h light-dark cycle and temperature of 22 ± 2 °C with free 
access to food and water. The animals were maintained in accordance with the Guiding Principles in 
the Care and Use of Animals of the Council of the American Physiological Society. The experimental 
protocol was approved by the Ethic Research Committee of PUCRS (CEUA 08/0010). 
3.9. Carrageenan-induced Pleurisy 
Animals were divided into groups of seven rats each. In the animals of the treated group, B. trimera 
was injected intraperitoneally (i.p.) in bolus (acute therapy), 30 min before the carrageenan-induced 
pleurisy [13]. The groups using B. trimera extracts were: DCM, EA, BU and AQ at doses of 25, 50 
and 75 mg/kg; SAP at doses of 15, 22.5 and 30 mg/kg; and PHE at doses of 5, 10 and 15 mg/kg.  
AQ extract was diluted in saline while all other extracts were solubilized with 1.0% of dimethyl 
sulfoxide (DMSO) in saline. In another group, dexamethasone was injected (s.c.) in bolus (1.0 mg/kg), 
30 min before the carrageenan-induced pleurisy. In the carrageenan group, saline solution was injected 
i.p. 30 min before the intrapleural (i.pl.) injection of carrageenan. In the control group, saline solution 
was injected both at i.pl. and i.p. routes. The pleurisy was induced by the injection of 0.2 mL of sterile 
saline solution (NaCl 0.9%) containing carrageenan (1%) into the right pleural space of animals under 
anesthesia. Animals were sacrificed 4 h later in an atmosphere of CO2. The chest was then carefully 
opened and the pleural cavity was rinsed with 2 mL of saline solution containing 1% EDTA.   
The exudates and rinse solution were removed by aspiration and the total volume was measured. 
Exudates contaminated with blood were discarded. The amount of exudates was calculated by 
subtracting the volume injected (2 mL) from the total volume recovered. Total leukocytes were diluted 
in Thoma solution (1:20) and counted in a Neubauer chamber using light microscopy. Cytological 
slide smears stained with May-Grünwald/Giemsa were used for differential leukocyte counts in a light 
microscope. The protein levels were determined by colorimetric using Biuret technique and the 
equipment COBAS MIRA PLUS (Roche Diagnostics). The amount of NO in the exudate was analyzed 
using the Griess reaction method that measures nitrite [21]. The inflammatory parameters evaluated 
were: volume of exudation in the pleural cavity, protein concentration in the exudate, total leukocytes 
count, leukocytes differential cell count and NO concentration. 
3.10. Data Analysis  
Results are expressed as means ± S.D. and statistical significance was determined by One-Way 
Analysis of Variance (ANOVA, p < 0.05). 
4. Conclusions 
In conclusion, phenolic extract of B. trimera presented anti-inflammatory activity at the dose of  
15 mg/kg, which is very potent. Also, this latter extract presented the highest phenolic content.   
These values are very significant in comparison to other compounds, such as ascorbic acid.   Molecules 2012, 17 1122 
 
 
These results indicate that it was possible to obtain an extract enriched in active compounds which 
should contribute to the discovery of lead compounds to design new drugs. 
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